Laura Tigli
Preclinical R&D
Parma, 43122, Italy
Parma, 43122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis.
Journal: ACS medicinal chemistry letters
Published: November 21, 2024
Design and synthesis of novel 8-(azaindolyl)-benzoazepinones as potent and selective ROCK inhibitors.
Journal: RSC medicinal chemistry
Published: April 30, 2024
Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic-ischaemic encephalopathy.
Journal: British journal of pharmacology
Published: March 08, 2024
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.
Journal: Journal of medicinal chemistry
Published: April 05, 2023
Sample preparation strategy for the detection of steroid-like compounds using MALDI mass spectrometry imaging: pulmonary distribution of budesonide as a case study.
Journal: Analytical and bioanalytical chemistry
Published: January 04, 2021
Surfactant lung delivery with LISA and InSurE in adult rabbits with respiratory distress.
Journal: Pediatric research
Published: August 13, 2020
Dexpramipexole improves bioenergetics and outcome in experimental stroke.
Journal: British journal of pharmacology
Published: December 16, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026